FREMONT, Calif.--(BUSINESS WIRE)--Cardima, Inc. (OTCBB: CADM) is a medical device company focused on the treatment of atrial fibrillation (AF) and manufacturer of the Cardima Surgical Ablation System and the REVELATION® line of therapeutic electrophysiology (EP) catheters. Cardima has successfully completed its second phase of training for cardiothoracic surgeons in Thailand on the use of the Cardima Surgical Ablation System, a true closed chest procedure for the treatment of AF. Cardima’s EP product lines and the Surgical Ablation System have received product registration approval in Thailand.
